ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 19 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6 | -62.5% | 26,473 | -42.4% | 0.00% | -100.0% |
| Q1 2023 | $16 | -15.8% | 45,994 | -47.4% | 0.00% | -33.3% |
| Q4 2022 | $19 | -99.9% | 87,405 | +12.5% | 0.00% | +50.0% |
| Q3 2022 | $27,000 | -37.2% | 77,694 | +142.7% | 0.00% | -50.0% |
| Q2 2022 | $43,000 | -45.6% | 32,013 | +3.1% | 0.00% | -50.0% |
| Q2 2021 | $79,000 | +88.1% | 31,038 | +64.2% | 0.01% | +14.3% |
| Q3 2020 | $42,000 | – | 18,902 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 77,694 | $27,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 36,461 | $12,000 | 0.00% |
| ROYAL BANK OF CANADA | 25 | $0 | 0.00% |
| VANGUARD GROUP INC | 616,855 | $216,000 | 0.00% |
| Private Advisor Group, LLC | 21,400 | $7,000 | 0.00% |
| UBS Group AG | 35,517 | $12,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 58,389 | $20,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,321 | $3,000 | 0.00% |
| FMR LLC | 7 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,005 | $0 | 0.00% |